Loading...
Header Logo
Keywords
Last Name
Institution

Chinthalapally Venkateshwar Rao

TitleProf,George L Cross Rsrch
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentMedicine Hematology/Oncology
Address975 NE 10th St
Oklahoma City OK 73104-5419
Phone405/271-3224
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    Osmania University, Hyderabad, INDIAMS1983Microbiology
    Osmania University, Hyderabad, INDIAPhD1987Microbiology
    American Health Foundation-Cancer Center, Valhalla, NYPostdoc1990Carcinogenesis/Chemoprevention

    Collapse Research 
    Collapse research activities and funding
    R01CA213278     (MUKHERJEE, PRIYABRATA)Dec 22, 2016 - Nov 30, 2021
    NIH/NCI
    Reprogramming Tumor Microenvironment by Nanoparticle
    Role: Co-Investigator

    R01CA213987     (RAO, CHINTHALAPALLY V.)Dec 15, 2016 - Nov 30, 2021
    NIH/NCI
    Safer Approaches to CRC Chemoprevention
    Role: Principal Investigator

    R01CA200126     (BENBROOK, DORIS MANGIARACINA)Jun 1, 2016 - May 31, 2022
    NIH/NCI
    Targeting HPV Consequences in a Cervical Cancer Clinical Trial
    Role: Co-Investigator

    I01BX003198     (RAO, CHINTHALAPALLY V.)Apr 1, 2016 - Sep 30, 2020
    VA
    Targeting mPGES-1/5-LOX for Prevention of CRC in High-Risk Veterans
    Role: Principal Investigator

    R01CA196200     (BENBROOK, DORIS MANGIARACINA)Jul 1, 2015 - Jun 30, 2020
    NIH/NCI
    Ovarian Cancer Chemoprevention
    Role: Co-Investigator

    5R01CA196200-03     (BENBROOK, DORIS MANGIARACINA)Jul 1, 2015 - Jun 30, 2020
    NIH
    Ovarian Cancer Chemoprevention
    Role: Co-Investigator

    261201200015I-0-26100001-1     Sep 20, 2012 - Sep 19, 2014
    NIH
    Preclinical Efficacy and Intermediate Endpoint Biomarkers Orientation Meeting
    Role: Co-Investigator

    R01CA109247     (RAO, CHINTHALAPALLY V.)Sep 23, 2004 - Jun 30, 2010
    NIH/NCI
    PREVENTION OF COLORECTAL CANCER BY iNOS AND COX-2 SELECTIVE INHIBITORS
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Rao CV. Immunomodulatory Effects of Momordica charantia Extract in the Prevention of Oral Cancer. Cancer Prev Res (Phila). 2018 Apr; 11(4):185-186. PMID: 29559516.
      View in: PubMed
    2. Benbrook DM, Janakiram NB, Chandra V, Pathuri G, Madka V, Stratton NC, Masamha CP, Farnsworth CN, Garcia-Contreras L, Hatipoglu MK, Lighfoot S, Rao CV. Development of a dietary formulation of the SHetA2 chemoprevention drug for mice. Invest New Drugs. 2018 08; 36(4):561-570. PMID: 29273857.
      View in: PubMed
    3. Mohammed A, Janakiram NB, Madka V, Pathuri G, Li Q, Ritchie R, Biddick L, Kutche H, Zhang Y, Singh A, Gali H, Lightfoot S, Steele VE, Suen CS, Rao CV. Lack of chemopreventive effects of P2X7R inhibitors against pancreatic cancer. Oncotarget. 2017 Nov 17; 8(58):97822-97834. PMID: 29228654.
      View in: PubMed
    4. Janakiram NB, Mohammed A, Bryant T, Ritchie R, Stratton N, Jackson L, Lightfoot S, Benbrook DM, Asch AS, Lang ML, Rao CV. Loss of natural killer T cells promotes pancreatic cancer in LSL-KrasG12D/+ mice. Immunology. 2017 09; 152(1):36-51. PMID: 28419443.
      View in: PubMed
    5. Rao CV, Pal S, Mohammed A, Farooqui M, Doescher MP, Asch AS, Yamada HY. Biological effects and epidemiological consequences of arsenic exposure, and reagents that can ameliorate arsenic damage in vivo. Oncotarget. 2017 Aug 22; 8(34):57605-57621. PMID: 28915699.
      View in: PubMed
    6. Putta S, Yarla NS, Peluso I, Tiwari DK, Reddy GV, Giri PV, Kumar N, Malla R, Rachel V, Bramhachari PV, Reddy D RS, Bade R, Mannarapu M, Barreto GE, Lu DY, Tarasov VV, Chubarev VN, Ribeiro FF, Scotti L, Scotti MT, Kamal MA, Ashraf GM, Aliev G, Perry G, Sarker SD, Rao CV, Bishayee A. Anthocyanins: Multi-Target Agents for Prevention and Therapy of Chronic Diseases. Curr Pharm Des. 2017; 23(41):6321-6346. PMID: 28741457.
      View in: PubMed
    7. Rao CV, Janakiram NB, Mohammed A. Molecular Pathways: Mucins and Drug Delivery in Cancer. Clin Cancer Res. 2017 Mar 15; 23(6):1373-1378. PMID: 28039261.
      View in: PubMed
    8. Janakiram NB, Mohammed A, Bryant T, Zhang Y, Brewer M, Duff A, Biddick L, Singh A, Lightfoot S, Steele VE, Rao CV. Potentiating NK cell activity by combination of Rosuvastatin and Difluoromethylornithine for effective chemopreventive efficacy against Colon Cancer. Sci Rep. 2016 11 14; 6:37046. PMID: 27841323.
      View in: PubMed
    9. Rao CV, Asch AS, Yamada HY. Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer. Carcinogenesis. 2017 01; 38(1):2-11. PMID: 27838634.
      View in: PubMed
    10. Miller MS, Allen P, Brentnall TA, Goggins M, Hruban RH, Petersen GM, Rao CV, Whitcomb DC, Brand RE, Chari ST, Klein AP, Lubman DM, Rhim AD, Simeone DM, Wolpin BM, Umar A, Srivastava S, Steele VE, Rinaudo JA. Pancreatic Cancer Chemoprevention Translational Workshop: Meeting Report. Pancreas. 2016 09; 45(8):1080-91. PMID: 27518363.
      View in: PubMed
    11. Rao CV, Asch AS, Yamada HY. Emerging links among Chromosome Instability (CIN), cancer, and aging. Mol Carcinog. 2017 03; 56(3):791-803. PMID: 27533343.
      View in: PubMed
    12. Yamada HY, Kumar G, Zhang Y, Rubin E, Lightfoot S, Dai W, Rao CV. Systemic chromosome instability in Shugoshin-1 mice resulted in compromised glutathione pathway, activation of Wnt signaling and defects in immune system in the lung. Oncogenesis. 2016 Aug 15; 5(8):e256. PMID: 27526110; PMCID: PMC5007830.
    13. Nguyen CB, Kotturi H, Waris G, Mohammed A, Chandrakesan P, May R, Sureban S, Weygant N, Qu D, Rao CV, Dhanasekaran DN, Bronze MS, Houchen CW, Ali N. (Z)-3,5,4'-Trimethoxystilbene Limits Hepatitis C and Cancer Pathophysiology by Blocking Microtubule Dynamics and Cell-Cycle Progression. Cancer Res. 2016 08 15; 76(16):4887-96. PMID: 27287718; PMCID: PMC4987271 [Available on 08/15/17].
    14. Kumar G, Patlolla JM, Madka V, Mohammed A, Li Q, Zhang Y, Biddick L, Singh A, Gillaspy A, Lightfoot S, Steele VE, Kopelovich L, Rao CV. Simultaneous targeting of 5-LOX-COX and ODC block NNK-induced lung adenoma progression to adenocarcinoma in A/J mice. Am J Cancer Res. 2016; 6(5):894-909. PMID: 27293987; PMCID: PMC4889708.
    15. Hsieh MY, Lai FI, Chen WC, Hsieh MC, Hu HY, Yu P, Kuo HC, Kuo SY. Realizing omnidirectional light harvesting by employing hierarchical architecture for dye sensitized solar cells. Nanoscale. 2016 Mar 14; 8(10):5478-87. PMID: 26899775.
      View in: PubMed
    16. Rao CV, Janakiram NB, Madka V, Kumar G, Scott EJ, Pathuri G, Bryant T, Kutche H, Zhang Y, Biddick L, Gali H, Zhao YD, Lightfoot S, Mohammed A. Small-Molecule Inhibition of GCNT3 Disrupts Mucin Biosynthesis and Malignant Cellular Behaviors in Pancreatic Cancer. Cancer Res. 2016 04 01; 76(7):1965-74. PMID: 26880801.
      View in: PubMed
    17. Park SH, Xie S, Rao CV, Dai W. Haplo-insufficiency of both BubR1 and SGO1 accelerates cellular senescence. J Hematol Oncol. 2016 Feb 04; 9:7. PMID: 26847209; PMCID: PMC4743409.
    18. Rao CV, Sanghera S, Zhang Y, Biddick L, Reddy A, Lightfoot S, Janakiram NB, Mohammed A, Dai W, Yamada HY. Systemic Chromosome Instability Resulted in Colonic Transcriptomic Changes in Metabolic, Proliferation, and Stem Cell Regulators in Sgo1-/+ Mice. Cancer Res. 2016 Feb 01; 76(3):630-42. PMID: 26833665; PMCID: PMC4750399 [Available on 02/01/17].
    19. Madka V, Mohammed A, Li Q, Zhang Y, Biddick L, Patlolla JM, Lightfoot S, Towner RA, Wu XR, Steele VE, Kopelovich L, Rao CV. Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo. Cancer Prev Res (Phila). 2016 Jan; 9(1):53-62. PMID: 26577454.
      View in: PubMed
    20. Rao CV, Janakiram NB, Madka V, Devarkonda V, Brewer M, Biddick L, Lightfoot S, Steele VE, Mohammed A. Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma. Oncotarget. 2015 Oct 20; 6(32):33290-305. PMID: 26429877; PMCID: PMC4741766.
    21. Patlolla JM, Kopelovich L, Qian L, Zhang Y, Kumar G, Madka V, Mohammed A, Biddick L, Sadeghi M, Lightfoot S, Rao CV. Early and delayed intervention with rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice. Oncol Rep. 2015 Dec; 34(6):2925-34. PMID: 26397133; PMCID: PMC4735698 [Available on 12/01/16].
    22. Madka V, Mohammed A, Li Q, Zhang Y, Kumar G, Lightfoot S, Wu X, Steele V, Kopelovich L, Rao CV. TP53 modulating agent, CP-31398 enhances antitumor effects of ODC inhibitor in mouse model of urinary bladder transitional cell carcinoma. Am J Cancer Res. 2015; 5(10):3030-41. PMID: 26693057; PMCID: PMC4656728.
    23. Mohammed A, Janakiram NB, Pant S, Rao CV. Molecular Targeted Intervention for Pancreatic Cancer. Cancers (Basel). 2015 Aug 10; 7(3):1499-542. PMID: 26266422; PMCID: PMC4586783.
    24. Mohammed A, Janakiram NB, Madka V, Brewer M, Ritchie RL, Lightfoot S, Kumar G, Sadeghi M, Patlolla JM, Yamada HY, Cruz-Monserrate Z, May R, Houchen CW, Steele VE, Rao CV. Targeting pancreatitis blocks tumor-initiating stem cells and pancreatic cancer progression. Oncotarget. 2015 Jun 20; 6(17):15524-39. PMID: 25906749; PMCID: PMC4558168.
    25. Janakiram NB, Mohammed A, Rao CV. Sea Cucumbers Metabolites as Potent Anti-Cancer Agents. Mar Drugs. 2015 May 12; 13(5):2909-23. PMID: 25984989; PMCID: PMC4446612.
    26. Rao CV, Mohammed A. New insights into pancreatic cancer stem cells. World J Stem Cells. 2015 Apr 26; 7(3):547-55. PMID: 25914762; PMCID: PMC4404390.
    27. Rao CV, Sanghera S, Zhang Y, Biddick L, Reddy A, Lightfoot S, Dai W, Yamada HY. Antagonizing pathways leading to differential dynamics in colon carcinogenesis in Shugoshin1 (Sgo1)-haploinsufficient chromosome instability model. Mol Carcinog. 2016 May; 55(5):600-10. PMID: 25773652; PMCID: PMC4569547 [Available on 05/01/17].
    28. Yamada HY, Zhang Y, Reddy A, Mohammed A, Lightfoot S, Dai W, Rao CV. Tumor-promoting/progressing role of additional chromosome instability in hepatic carcinogenesis in Sgo1 (Shugoshin 1) haploinsufficient mice. Carcinogenesis. 2015 Apr; 36(4):429-40. PMID: 25740822; PMCID: PMC4392605.
    29. Janakiram NB, Mohammed A, Bryant T, Lightfoot S, Collin PD, Steele VE, Rao CV. Improved innate immune responses by Frondanol A5, a sea cucumber extract, prevent intestinal tumorigenesis. Cancer Prev Res (Phila). 2015 Apr; 8(4):327-37. PMID: 25657017.
      View in: PubMed
    30. Mohammed A, Janakiram NB, Madka V, Ritchie RL, Brewer M, Biddick L, Patlolla JM, Sadeghi M, Lightfoot S, Steele VE, Rao CV. Eflornithine (DFMO) prevents progression of pancreatic cancer by modulating ornithine decarboxylase signaling. Cancer Prev Res (Phila). 2014 Dec; 7(12):1198-209. PMID: 25248858.
      View in: PubMed
    31. Pathuri G, Madka V, Hedrick AF, Lightfoot SA, Awasthi V, Cowley BD, Rao CV, Gali H. Evaluation of (99m)Tc-probestin SPECT as a novel technique for noninvasive imaging of kidney aminopeptidase N expression. Mol Pharm. 2014 Aug 04; 11(8):2948-53. PMID: 24988047; PMCID: PMC4144757.
    32. Janakiram NB, Mohammed A, Bryant T, Brewer M, Biddick L, Lightfoot S, Lang ML, Rao CV. Adoptive transfer of regulatory T cells promotes intestinal tumorigenesis and is associated with decreased NK cells and IL-22 binding protein. Mol Carcinog. 2015 Oct; 54(10):986-98. PMID: 24797894.
      View in: PubMed
    33. Madka V, Mohammed A, Li Q, Zhang Y, Patlolla JM, Biddick L, Lightfoot S, Wu XR, Steele V, Kopelovich L, Rao CV. Chemoprevention of urothelial cell carcinoma growth and invasion by the dual COX-LOX inhibitor licofelone in UPII-SV40T transgenic mice. Cancer Prev Res (Phila). 2014 Jul; 7(7):708-16. PMID: 24795386.
      View in: PubMed
    34. Pathuri G, Li Q, Mohammed A, Gali H, Pento JT, Rao CV. Synthesis and in vivo evaluation of N-ethylamino-2-oxo-1,2-dihydro-quinoline-3-carboxamide for inhibition of intestinal tumorigenesis in APC(Min/+) mice. Bioorg Med Chem Lett. 2014 Mar 01; 24(5):1380-2. PMID: 24507628; PMCID: PMC3966088.
    35. Janakiram NB, Mohammed A, Brewer M, Bryant T, Biddick L, Lightfoot S, Pathuri G, Gali H, Rao CV. Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells. Cancer Prev Res (Phila). 2014 Mar; 7(3):300-9. PMID: 24431404; PMCID: PMC3951612.
    36. Janakiram NB, Rao CV. The role of inflammation in colon cancer. Adv Exp Med Biol. 2014; 816:25-52. PMID: 24818718.
      View in: PubMed
    37. Mohammed A, Janakiram NB, Brewer M, Ritchie RL, Marya A, Lightfoot S, Steele VE, Rao CV. Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling. Transl Oncol. 2013 Dec 01; 6(6):649-59. PMID: 24466367; PMCID: PMC3890699.
    38. Ravillah D, Mohammed A, Qian L, Brewer M, Zhang Y, Biddick L, Steele VE, Rao CV. Chemopreventive effects of an HDAC2-selective inhibitor on rat colon carcinogenesis and APCmin/+ mouse intestinal tumorigenesis. J Pharmacol Exp Ther. 2014 Jan; 348(1):59-68. PMID: 24218540; PMCID: PMC3868878.
    39. Janakiram NB, Mohammed A, Zhang Y, Brewer M, Bryant T, Lightfoot S, Steele VE, Rao CV. Chemopreventive efficacy of raloxifene, bexarotene, and their combination on the progression of chemically induced colon adenomas to adenocarcinomas in rats. Cancer Prev Res (Phila). 2013 Dec; 6(12):1251-61. PMID: 24080207.
      View in: PubMed
    40. Sureban SM, May R, Qu D, Weygant N, Chandrakesan P, Ali N, Lightfoot SA, Pantazis P, Rao CV, Postier RG, Houchen CW. DCLK1 regulates pluripotency and angiogenic factors via microRNA-dependent mechanisms in pancreatic cancer. PLoS One. 2013; 8(9):e73940. PMID: 24040120; PMCID: PMC3767662.
    41. Rao CV, Patlolla JM, Qian L, Zhang Y, Brewer M, Mohammed A, Desai D, Amin S, Lightfoot S, Kopelovich L. Chemopreventive effects of the p53-modulating agents CP-31398 and Prima-1 in tobacco carcinogen-induced lung tumorigenesis in A/J mice. Neoplasia. 2013 Sep; 15(9):1018-27. PMID: 24027427; PMCID: PMC3769881.
    42. Patlolla JM, Qian L, Biddick L, Zhang Y, Desai D, Amin S, Lightfoot S, Rao CV. ß-Escin inhibits NNK-induced lung adenocarcinoma and ALDH1A1 and RhoA/Rock expression in A/J mice and growth of H460 human lung cancer cells. Cancer Prev Res (Phila). 2013 Oct; 6(10):1140-9. PMID: 23963803.
      View in: PubMed
    43. Madka V, Zhang Y, Li Q, Mohammed A, Sindhwani P, Lightfoot S, Wu XR, Kopelovich L, Rao CV. p53-stabilizing agent CP-31398 prevents growth and invasion of urothelial cancer of the bladder in transgenic UPII-SV40T mice. Neoplasia. 2013 Aug; 15(8):966-74. PMID: 23908596; PMCID: PMC3730047.
    44. Benbrook DM, Guruswamy S, Wang Y, Sun Z, Mohammed A, Zhang Y, Li Q, Rao CV. Chemoprevention of colon and small intestinal tumorigenesis in APC(min/+) mice by SHetA2 (NSC721689) without toxicity. Cancer Prev Res (Phila). 2013 Sep; 6(9):908-16. PMID: 23852423; PMCID: PMC3769959.
    45. Rao CV. Benzyl isothiocyanate: double trouble for breast cancer cells. Cancer Prev Res (Phila). 2013 Aug; 6(8):760-3. PMID: 23842793.
      View in: PubMed
    46. Hocker JR, Mohammed A, Aston CE, Brewer M, Lightfoot SA, Rao CV, Hanas JS. Mass profiling of serum to distinguish mice with pancreatic cancer induced by a transgenic Kras mutation. Int J Cancer. 2013 Dec 01; 133(11):2662-71. PMID: 23712558.
      View in: PubMed
    47. Madka V, Rao CV. Anti-inflammatory phytochemicals for chemoprevention of colon cancer. Curr Cancer Drug Targets. 2013 Jun; 13(5):542-57. PMID: 23597198.
      View in: PubMed
    48. Janakiram NB, Mohammed A, Ravillah D, Choi CI, Zhang Y, Desai D, Amin S, Rao CV. Chemopreventive effects of PBI-Se, a selenium-containing analog of PBIT, on AOM-induced aberrant crypt foci in F344 rats. Oncol Rep. 2013 Aug; 30(2):952-60. PMID: 23708609.
      View in: PubMed
    49. Rao CV, Yamada HY. Genomic instability and colon carcinogenesis: from the perspective of genes. Front Oncol. 2013; 3:130. PMID: 23734346; PMCID: PMC3659308.
    50. Mohammed A, Janakiram NB, Brewer M, Vedala K, Steele VE, Rao CV. Multitargeted low-dose GLAD combination chemoprevention: a novel and promising approach to combat colon carcinogenesis. Neoplasia. 2013 May; 15(5):481-90. PMID: 23633920; PMCID: PMC3638351.
    51. Rao CV, Patlolla JM, Cooma I, Kawamori T, Steele VE. Prevention of familial adenomatous polyp development in APC min mice and azoxymethane-induced colon carcinogenesis in F344 Rats by ?-3 fatty acid rich perilla oil. Nutr Cancer. 2013; 65 Suppl 1:54-60. PMID: 23682783.
      View in: PubMed
    52. Rao CV, Kurkjian CD, Yamada HY. Mitosis-targeting natural products for cancer prevention and therapy. Curr Drug Targets. 2012 Dec; 13(14):1820-30. PMID: 23140292.
      View in: PubMed
    53. Mohammed A, Janakiram NB, Brewer M, Duff A, Lightfoot S, Brush RS, Anderson RE, Rao CV. Endogenous n-3 polyunsaturated fatty acids delay progression of pancreatic ductal adenocarcinoma in Fat-1-p48(Cre/+)-LSL-Kras(G12D/+) mice. Neoplasia. 2012 Dec; 14(12):1249-59. PMID: 23308056; PMCID: PMC3540949.
    54. Rao CV, Janakiram NB, Mohammed A. Lipoxygenase and Cyclooxygenase Pathways and Colorectal Cancer Prevention. Curr Colorectal Cancer Rep. 2012 Dec; 8(4):316-324. PMID: 23293573.
      View in: PubMed
    55. Janakiram NB, Rao CV. iNOS-selective inhibitors for cancer prevention: promise and progress. Future Med Chem. 2012 Nov; 4(17):2193-204. PMID: 23190107; PMCID: PMC3588580.
    56. Rao CV, Mohammed A, Janakiram NB, Li Q, Ritchie RL, Lightfoot S, Vibhudutta A, Steele VE. Inhibition of pancreatic intraepithelial neoplasia progression to carcinoma by nitric oxide-releasing aspirin in p48(Cre/+)-LSL-Kras(G12D/+) mice. Neoplasia. 2012 Sep; 14(9):778-87. PMID: 23019409; PMCID: PMC3459273.
    57. Everly MJ, Terasaki PI, Trivedi HL. Durability of antibody removal following proteasome inhibitor-based therapy. Transplantation. 2012 Mar 27; 93(6):572-7. PMID: 22262128.
      View in: PubMed
    58. Mohammed A, Qian L, Janakiram NB, Lightfoot S, Steele VE, Rao CV. Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48Cre/+ LSL-KrasG12D/+ mice. Int J Cancer. 2012 Oct 15; 131(8):1951-62. PMID: 22287227; PMCID: PMC3376252.
    59. Janakiram NB, Mohammed A, Qian L, Choi CI, Steele VE, Rao CV. Chemopreventive effects of RXR-selective rexinoid bexarotene on intestinal neoplasia of Apc(Min/+) mice. Neoplasia. 2012 Feb; 14(2):159-68. PMID: 22431924; PMCID: PMC3306261.
    60. Yamada HY, Yao Y, Wang X, Zhang Y, Huang Y, Dai W, Rao CV. Haploinsufficiency of SGO1 results in deregulated centrosome dynamics, enhanced chromosomal instability and colon tumorigenesis. Cell Cycle. 2012 Feb 01; 11(3):479-88. PMID: 22262168; PMCID: PMC3315092.
    61. Janakiram NB, Rao CV. Chemoprevention of Colon Cancer by iNOS-Selective Inhibitors. For Immunopathol Dis Therap. 2012 Jan 01; 3(2):155-167. PMID: 23678395.
      View in: PubMed
    62. Patlolla JM, Rao CV. Triterpenoids for cancer prevention and treatment: current status and future prospects. Curr Pharm Biotechnol. 2012 Jan; 13(1):147-55. PMID: 21466427.
      View in: PubMed
    63. Mohammed A, Janakiram NB, Lightfoot S, Gali H, Vibhudutta A, Rao CV. Early detection and prevention of pancreatic cancer: use of genetically engineered mouse models and advanced imaging technologies. Curr Med Chem. 2012; 19(22):3701-13. PMID: 22680929.
      View in: PubMed
    64. Janakiram NB, Mohammed A, Bronze MS, Rao CV. Prophylactic vaccine approach for colon and pancreatic cancers: present and future. Curr Med Chem. 2012; 19(22):3664-78. PMID: 22680926.
      View in: PubMed
    65. Janakiram NB, Mohammed A, Rao CV. Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer. Cancer Metastasis Rev. 2011 Dec; 30(3-4):507-23. PMID: 22015691.
      View in: PubMed
    66. Madka V, Rao CV. Cancer stem cell markers as potential targets for epithelial cancers. Indian J Exp Biol. 2011 Nov; 49(11):826-35. PMID: 22126013.
      View in: PubMed
    67. Patlolla JM, Zhang Y, Li Q, Steele VE, Rao CV. Anti-carcinogenic properties of omeprazole against human colon cancer cells and azoxymethane-induced colonic aberrant crypt foci formation in rats. Int J Oncol. 2012 Jan; 40(1):170-5. PMID: 21956158.
      View in: PubMed
    68. Mohammed A, Janakiram NB, Li Q, Choi CI, Zhang Y, Steele VE, Rao CV. Chemoprevention of colon and small intestinal tumorigenesis in APC(Min/+) mice by licofelone, a novel dual 5-LOX/COX inhibitor: potential implications for human colon cancer prevention. Cancer Prev Res (Phila). 2011 Dec; 4(12):2015-26. PMID: 21885812; PMCID: PMC3232346.
    69. Boyer TH, Persaud A, Banerjee P, Palomino P. Comparison of low-cost and engineered materials for phosphorus removal from organic-rich surface water. Water Res. 2011 Oct 15; 45(16):4803-14. PMID: 21767859.
      View in: PubMed
    70. Joyner PM, Waters AL, Williams RB, Powell DR, Janakiram NB, Rao CV, Cichewicz RH. Briarane diterpenes diminish COX-2 expression in human colon adenocarcinoma cells. J Nat Prod. 2011 Apr 25; 74(4):857-61. PMID: 21438584.
      View in: PubMed
    71. Sureban SM, May R, Lightfoot SA, Hoskins AB, Lerner M, Brackett DJ, Postier RG, Ramanujam R, Mohammed A, Rao CV, Wyche JH, Anant S, Houchen CW. DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism. Cancer Res. 2011 Mar 15; 71(6):2328-38. PMID: 21285251; PMCID: PMC3072762.
    72. Mohammed A, Janakiram NB, Li Q, Madka V, Ely M, Lightfoot S, Crawford H, Steele VE, Rao CV. The epidermal growth factor receptor inhibitor gefitinib prevents the progression of pancreatic lesions to carcinoma in a conditional LSL-KrasG12D/+ transgenic mouse model. Cancer Prev Res (Phila). 2010 Nov; 3(11):1417-26. PMID: 21084261; PMCID: PMC3058550.
    73. Yamada HY, Rao CV. Genes that modulate the sensitivity for anti-microtubule drug-mediated chemotherapy. Curr Cancer Drug Targets. 2010 Sep; 10(6):623-33. PMID: 20491618.
      View in: PubMed
    74. May R, Sureban SM, Lightfoot SA, Hoskins AB, Brackett DJ, Postier RG, Ramanujam R, Rao CV, Wyche JH, Anant S, Houchen CW. Identification of a novel putative pancreatic stem/progenitor cell marker DCAMKL-1 in normal mouse pancreas. Am J Physiol Gastrointest Liver Physiol. 2010 Aug; 299(2):G303-10. PMID: 20522640; PMCID: PMC2928534.
    75. Janakiram NB, Mohammed A, Zhang Y, Choi CI, Woodward C, Collin P, Steele VE, Rao CV. Chemopreventive effects of Frondanol A5, a Cucumaria frondosa extract, against rat colon carcinogenesis and inhibition of human colon cancer cell growth. Cancer Prev Res (Phila). 2010 Jan; 3(1):82-91. PMID: 20051375.
      View in: PubMed
    76. Guruswamy S, Rao CV. Synergistic effects of lovastatin and celecoxib on caveolin-1 and its down-stream signaling molecules: Implications for colon cancer prevention. Int J Oncol. 2009 Nov; 35(5):1037-43. PMID: 19787257.
      View in: PubMed
    77. Yamada HY, Rao CV. BRD8 is a potential chemosensitizing target for spindle poisons in colorectal cancer therapy. Int J Oncol. 2009 Nov; 35(5):1101-9. PMID: 19787264.
      View in: PubMed
    78. Rao CV, Steele VE, Swamy MV, Patlolla JM, Guruswamy S, Kopelovich L. Inhibition of azoxymethane-induced colorectal cancer by CP-31398, a TP53 modulator, alone or in combination with low doses of celecoxib in male F344 rats. Cancer Res. 2009 Oct 15; 69(20):8175-82. PMID: 19826045; PMCID: PMC2792897.
    79. Janakiram NB, Rao CV. Role of lipoxins and resolvins as anti-inflammatory and proresolving mediators in colon cancer. Curr Mol Med. 2009 Jun; 9(5):565-79. PMID: 19601807.
      View in: PubMed
    80. Rao CV, Yamada HY, Yao Y, Dai W. Enhanced genomic instabilities caused by deregulated microtubule dynamics and chromosome segregation: a perspective from genetic studies in mice. Carcinogenesis. 2009 Sep; 30(9):1469-74. PMID: 19372138; PMCID: PMC2736299.
    81. Rao CV, Cohen L, El-Bayoumy K. Bandaru S. Reddy: in memoriam (1930-2009). Nutr Cancer. 2009; 61(6):903-5. PMID: 20155634.
      View in: PubMed
    82. Janakiram NB, Steele VE, Rao CV. Estrogen receptor-beta as a potential target for colon cancer prevention: chemoprevention of azoxymethane-induced colon carcinogenesis by raloxifene in F344 rats. Cancer Prev Res (Phila). 2009 Jan; 2(1):52-9. PMID: 19139018.
      View in: PubMed
    83. Mandal MN, Patlolla JM, Zheng L, Agbaga MP, Tran JT, Wicker L, Kasus-Jacobi A, Elliott MH, Rao CV, Anderson RE. Curcumin protects retinal cells from light-and oxidant stress-induced cell death. Free Radic Biol Med. 2009 Mar 01; 46(5):672-9. PMID: 19121385; PMCID: PMC2810836.
    84. Rao CV, Joseph S, Gao L, Patlolla JM, Choi CI, Kopelovich L, Steele VE, Rigas B. Pharmacokinetic and pharmacodynamic study of NO-donating aspirin in F344 rats. Int J Oncol. 2008 Oct; 33(4):799-805. PMID: 18813794; PMCID: PMC2579329.
    85. Rao CV, Swamy MV, Patlolla JM, Kopelovich L. Suppression of familial adenomatous polyposis by CP-31398, a TP53 modulator, in APCmin/+ mice. Cancer Res. 2008 Sep 15; 68(18):7670-5. PMID: 18794156; PMCID: PMC2597360.
    86. Guruswamy S, Rao CV. Multi-Target Approaches in Colon Cancer Chemoprevention Based on Systems Biology of Tumor Cell-Signaling. Gene Regul Syst Bio. 2008 May 02; 2:163-176. PMID: 19763245.
      View in: PubMed
    87. Janakiram NB, Indranie C, Malisetty SV, Jagan P, Steele VE, Rao CV. Chemoprevention of colon carcinogenesis by oleanolic acid and its analog in male F344 rats and modulation of COX-2 and apoptosis in human colon HT-29 cancer cells. Pharm Res. 2008 Sep; 25(9):2151-7. PMID: 18408893.
      View in: PubMed
    88. Swamy MV, Citineni B, Patlolla JM, Mohammed A, Zhang Y, Rao CV. Prevention and treatment of pancreatic cancer by curcumin in combination with omega-3 fatty acids. Nutr Cancer. 2008; 60 Suppl 1:81-9. PMID: 19003584.
      View in: PubMed
    89. Guruswamy S, Swamy MV, Choi CI, Steele VE, Rao CV. S-adenosyl L-methionine inhibits azoxymethane-induced colonic aberrant crypt foci in F344 rats and suppresses human colon cancer Caco-2 cell growth in 3D culture. Int J Cancer. 2008 Jan 01; 122(1):25-30. PMID: 17724725.
      View in: PubMed
    90. Janakiram NB, Rao CV. Molecular markers and targets for colorectal cancer prevention. Acta Pharmacol Sin. 2008 Jan; 29(1):1-20. PMID: 18158862.
      View in: PubMed
    91. Rao CV. Regulation of COX and LOX by curcumin. Adv Exp Med Biol. 2007; 595:213-26. PMID: 17569213.
      View in: PubMed
    92. Swamy MV, Patlolla JM, Steele VE, Kopelovich L, Reddy BS, Rao CV. Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APCMin mice. Cancer Res. 2006 Jul 15; 66(14):7370-7. PMID: 16849589.
      View in: PubMed
    93. Rao CV, Reddy BS, Steele VE, Wang CX, Liu X, Ouyang N, Patlolla JM, Simi B, Kopelovich L, Rigas B. Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets. Mol Cancer Ther. 2006 Jun; 5(6):1530-8. PMID: 16818512.
      View in: PubMed
    94. Patlolla JM, Raju J, Swamy MV, Rao CV. Beta-escin inhibits colonic aberrant crypt foci formation in rats and regulates the cell cycle growth by inducing p21(waf1/cip1) in colon cancer cells. Mol Cancer Ther. 2006 Jun; 5(6):1459-66. PMID: 16818504.
      View in: PubMed
    95. Reddy BS, Patlolla JM, Simi B, Wang SH, Rao CV. Prevention of colon cancer by low doses of celecoxib, a cyclooxygenase inhibitor, administered in diet rich in omega-3 polyunsaturated fatty acids. Cancer Res. 2005 Sep 01; 65(17):8022-7. PMID: 16140976.
      View in: PubMed
    96. Rao CV, Yang YM, Swamy MV, Liu T, Fang Y, Mahmood R, Jhanwar-Uniyal M, Dai W. Colonic tumorigenesis in BubR1+/-ApcMin/+ compound mutant mice is linked to premature separation of sister chromatids and enhanced genomic instability. Proc Natl Acad Sci U S A. 2005 Mar 22; 102(12):4365-70. PMID: 15767571; PMCID: PMC555497.
    97. Rao CV, Hirose Y, Indranie C, Reddy BS. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res. 2001 Mar 01; 61(5):1927-33. PMID: 11280748.
      View in: PubMed
    98. Reddy BS, Hirose Y, Cohen LA, Simi B, Cooma I, Rao CV. Preventive potential of wheat bran fractions against experimental colon carcinogenesis: implications for human colon cancer prevention. Cancer Res. 2000 Sep 01; 60(17):4792-7. PMID: 10987288.
      View in: PubMed
    99. Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Cancer Res. 2000 Jan 15; 60(2):293-7. PMID: 10667579.
      View in: PubMed
    100. Reddy BS, Rivenson A, El-Bayoumy K, Upadhyaya P, Pittman B, Rao CV. Chemoprevention of colon cancer by organoselenium compounds and impact of high- or low-fat diets. J Natl Cancer Inst. 1997 Apr 02; 89(7):506-12. PMID: 9086007.
      View in: PubMed
    101. Rao CV, Desai D, Rivenson A, Simi B, Amin S, Reddy BS. Chemoprevention of colon carcinogenesis by phenylethyl-3-methylcaffeate. Cancer Res. 1995 Jun 01; 55(11):2310-5. PMID: 7757981.
      View in: PubMed
    102. Rao CV, Rivenson A, Simi B, Zang E, Kelloff G, Steele V, Reddy BS. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res. 1995 Apr 01; 55(7):1464-72. PMID: 7882354.
      View in: PubMed
    103. Rao CV, Rivenson A, Simi B, Reddy BS. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res. 1995 Jan 15; 55(2):259-66. PMID: 7812955.
      View in: PubMed
    Rao's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _